Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4462
+0.0034 (0.77%)
Sep 3, 2026, 3:25 PM EDT - Market open
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $8.68 million as of September 3, 2026. Its market cap has increased by 40.61% in one year.
Market Cap
8.68M
Enterprise Value
8.20M
1-Year Change
40.61%
Ranking
Category
Stock Price
$0.45
ChartMarket Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $8.68M, a decrease of -99.99%. That is a compound annual growth rate of -64.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 8.68M | 159.79% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 9.96M |
| CNS Pharmaceuticals | 8.78M |
| Traws Pharma | 8.76M |
| Imunon | 8.75M |
| Immuron | 8.57M |
| Exicure | 8.44M |
| Soligenix | 8.31M |
| Skye Bioscience | 8.15M |